IDEXX Laboratories Narrows FY24 EPS Outlook Range, But Trims Revenue Forecast - Update

(RTTNews) - While reporting financial results for the third quarter on Thursday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) narrowed its earnings guidance range for the full-year 2024, while trimming revenue outlook.

For fiscal 2024, the company now projects earnings in a range of $10.37 to $10.53 per share on revenues between $3.865 billion and $3.890 billion, with revenue growth of 5.5 to 6.2 percent and organic revenue growth of 5.3 to 6.0 percent.

Previously, the company expected earnings in the range of $10.31 to $10.59 per share on revenues between $3.885 billion and $3.945 billion, with revenue growth and organic revenue growth of 6.2 to 7.8 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $10.56 per share on revenues of $3.92 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com